Normal fasting triglyceride levels and incident type 2 diabetes in the general population

HIGHLIGHTS

• who: Tamas Szili-Torok from the The Prevention of Renal and Vascular End-stage Disease (PREVEND) study is a prospective longitudinal cohort study from the Northern Netherlands [7]PREVEND was approved by the medical ethics committee of the University Medical Center Groningen (MEC96/01/022) and carried out according to the Declaration of Helsinki. All participants provided written informed consent. Individuals between , and , years of age were invited to participate. Pregnant women and subjects using insulin were excluded leaving , participants for the initial screening (1997-1998). Five thousand seven hundred and sixtynine participants had complete data with . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.